Skip to main content

Spectral AI, Inc. (MDAI) Stock Forecast

Data as of May 20, 2026

Healthcare · Current price $2.38 (+6.03%)

Consensus Target
$3.50
Upside
+46.1%
Analysts
2
Rating
Buy(2.00)

Price Target Range

Low $3.50High $3.50

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

MDAI vs Sector & Market

MetricMDAIHealthcare AvgLarge Cap Avg
Analyst Rating2.002.242.41
Analyst Count2819
Target Upside+46.1%+2751.2%+18.1%
P/E Ratio-7.513.3727.91

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$19M$19M$19M2
2027-12-31$17M$23M$29M2
2028-12-31$6M$8M$11M1
2029-12-31$9M$13M$17M1
2030-12-31$13M$18M$23M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-0.50$-0.48$-0.452
2027-12-31$-0.66$-0.54$-0.432
2028-12-31$-1.32$-0.96$-0.591
2029-12-31$-0.11$-0.08$-0.051
2030-12-31$0.00$0.00$0.000

Frequently Asked Questions

What is the analyst consensus for MDAI?

The consensus among 2 analysts covering Spectral AI, Inc. (MDAI) is Buy with an average price target of $3.50.

What is the highest price target for MDAI?

The highest analyst price target for MDAI is $3.50.

What is the lowest price target for MDAI?

The lowest analyst price target for MDAI is $3.50.

How many analysts cover MDAI?

2 analysts have issued ratings for Spectral AI, Inc. in the past 12 months.

Is MDAI a buy or sell right now?

Based on 2 analyst ratings, MDAI has a consensus rating of Buy (2.00/5) with a +46.1% upside to the consensus target of $3.50.

What are the earnings estimates for MDAI?

Analysts estimate MDAI will report EPS of $-0.48 for the period ending 2026-12-31, with revenue estimated at $19M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.